Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Recommendations on the use of 18F-FDG PET in oncology 3. Taxane-based combinations as adjuvant chemotherapy of early breast cancer: a meta-analysis of randomized trials 4. Gene expression signatures, clinicopathological features, and individualized therapy in breast cancer 5. Sentinel node biopsy is important in mastectomy for ductal carcinoma in situ
Top Ten Searches
brca1 prostate-specific antigen sclc fobt egd bmi dysplasia hematologic ovarian hccYour Article Summary
See Latest ArticlesEscalating doses of donor lymphocytes for incipient graft rejection following SCT for thalassemia
Bone Marrow Transplantation, 11/05/09
Frugnoli I et al. – Escalating doses of DLI are safe in thalassemia patients post myeloablative therapy but efficacy may be jeopardized by rapidly growing anti–donor alloimmunity in high–risk patients. The authors suggest giving escalating doses of donor T cells to attempt a graft–versus–thalassemia as soon as level 2–3 MC is detected.
Today in Anemia/Polycythemia...keeping you current
Receive free subspecialty "5-minute updates" via email
Src tyrosine kinase pre-activation is associated with platelet hypersensitivity in essential thrombocythemia and polycythemia vera
Blood, 11/24/09
Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia
Blood, 11/24/09
Today in BMT/SCT...keeping you current
Receive free subspecialty "5-minute updates" via email
Purified T-depleted, CD34+ peripheral blood and bone marrow cell transplantation from haploidentical mother to child with thalassemia
Blood, 11/24/09
Health-related quality of life following haematopoietic cell transplantation: patient education, evaluation and intervention
British Journal of Haematology, 11/24/09
Sponsor
Article Search
Sponsor
Sponsor